The inverse relationship between HPV status and high MDM2 expression is consistent with several studies showing that HPV+ HNSCC patients appear to have a significantly improved response to radiotherapy and chemotherapy, in addition to a lower risk of second primary cancers than the HPV- (56). The gene discussed is MDM2; the disease is head and neck squamous cell carcinoma.